Get started
ENTGEntegris inc look a decent bet who is currently trading at $142 and deutsch bank have raised share price positive to $200 from $152 . Gross margin improved to 47.6% from 44.4% year-over-year and 46.9% sequentially. Operating margin rose to 18.6% from 13.4% year-over-year and 17.4% sequentially. Net income for Q2 2026 was $93.6 million, up from $52.8 million in Q2 2025 and $92.0 million in Q1 2026. Adjusted EBITDA margin increased to 28.4% from 27.3% year-over-year and 27.8% sequentially. Six-month net sales reached $1,695.1 million, with net income of $185.6 million and diluted EPS of $1.21.
NASDAQ:ENTGLong
by malbooth
RMBS: Ready to Launch Again? Round Bottom RetestPreviously posted short target has been achieved (See attached) Story: 📊 The Pattern RMBS broke out of a multi-year round bottom base, rallied hard to an all-time high near $174, then reversed sharply in a V-shape — falling all the way back down to retest the exact same base it launched from. ⚡ The Signal This week's candle is a strong bullish reversal right at the retest zone, backed by a volume spike to 20 million+ shares — real demand showing up at the level that originally launched the move. 🎯 Levels to Watch 🟢 Base / retest zone: $80 🔴 Resistance 1: $104 🔴 Resistance 2: $128 🔴 Resistance 3: $160 🏔️ All-time high: $174 🧠 The Read: A stock that round-trips from breakout to all-time high and back to the exact same base, then prints a high-volume bullish reversal right at that zone, is showing the base still matters. Same structure that launched the first move, now testing whether it can do it again. Chart study, not financial advice.
NASDAQ:RMBSLong
by ibraheeemz
1
RMBS: Bull Run Over? Major Breakdown Signals Deeper CorrectionRMBS has confirmed a major technical breakdown, suggesting its long-term bullish trend has come to an end. After breaking down from a Rising Wedge, the stock has now lost the critical 119 support on exceptionally strong volume—a bearish confirmation that sellers are in control. Key Technical Observations: 📉 Confirmed Rising Wedge breakdown, a classic bearish reversal pattern. 🔻 Decisive break below the major 119 support on heavy volume, adding conviction to the breakdown. 🎯 The measured target from the Rising Wedge points toward the 70s, implying substantial downside if the bearish trend continues. While short-term relief rallies are always possible, they are likely to remain corrective unless the stock can reclaim key resistance. Bullish Invalidation The bearish thesis would be invalidated only if RMBS can reclaim and close decisively above 150, indicating that buyers have regained control and the recent breakdown was a false move. Until then, the technical outlook favors further downside, with the wedge target in the 70s remaining the primary objective.
NASDAQ:RMBSShort
by ibraheeemz
1
Is RCAT Loading Another 150% Explosive Rally?RCAT has one characteristic that immediately stands out—it respects structure remarkably well. For a couple of years, the stock has been trading inside a well-defined ascending channel, repeatedly bouncing between support and resistance. Every major pullback has eventually found buyers near the lower trendline, setting the stage for another impulsive move higher. Now, RCAT is back at that same decision point. 📊 The Story Price has once again established a base at the lower boundary of the rising channel, where buyers have stepped in multiple times before. If history continues to rhyme, this could become the launchpad for another leg higher. The previous rallies from channel support have produced gains of well over 150%, making this area worth watching closely. As long as the channel remains intact, the broader uptrend is still alive. 🎯 Bullish Scenario A sustained rebound from current levels could target: 🎯 $11.5– Mid-channel resistance 🎯 $15–16 – Previous swing highs 🎯 $18–19 – Upper channel resistance ⚠️ What I'm Watching The lower trendline has done its job once again—but confirmation is still needed. Ideally, I'd like to see: ✅ Higher highs and higher lows on lower timeframes ✅ Increasing buying volume ✅ A breakout above the channel's midline to confirm momentum has returned Until then, patience remains the edge. ❌ Invalidation A decisive daily close below the lower channel support (around $7) would invalidate this bullish thesis and suggest the current structure has broken down. 📖 Every Chart Tells a Story. This one isn't predicting another 170% rally—it simply highlights that RCAT is once again sitting at the same high-probability area from which previous major advances began. Whether history repeats itself or not, price will reveal the answer soon.
NASDAQ:RCATLong
by ibraheeemz
6
GKOS: The Round Bottom RetestStory: 📊 The Pattern GKOS spent over a year carving out a round bottom from the ~$73 low, breaking above the $162 neckline on increased volume, then pulling back to retest that same neckline before bouncing. ⚡ The Confirmation Volume stepped up on the breakout, and the retest held — the pullback found buyers at the neckline instead of slipping back into the base. 🎯 Levels to Watch 🟢 Thesis intact above: $159 (weekly close) 🔵 Target 1: $191 (recent high) 🔵 Target 2: $210 🔵 Target 3: $230 🏁 Measured target: $249 🧠 The Read: A round bottom breakout that comes back to retest the neckline and holds is a healthier entry than chasing the initial breakout candle. With volume confirming and the neckline holding, the path toward the measured target stays open in stepped fashion — scaling out at each level rather than expecting a straight run. Chart study, not financial advice.
NYSE:GKOSLong
by ibraheeemz
LVMH MOET HENNESSY LOUIS VUITTON SE (MC:FR)LVMH MOET HENNESSY LOUIS VUITTON SE (MC:FR) Incredible pricing power (gross margin ~68%), a pristine balance sheet, strong FCF, and the fact that the Arnault family (insiders) continues to actively buy shares make LVMH one of the highest-quality "compounders" in the world at a very reasonable price (P/E ~21x). 💰 Accumulation Plan 🟡 $335 → 20% 🟠 $262→ 40% 🔴 $207 → 60% 🔴 $160→ 80% 🔴 $144→ 100% 🏦 Fundamentals → WHAT I want to own 📊 Technical Levels → WHERE I want to accumulate ⏳ Patience → WHEN I choose to act The market constantly creates imbalances. My job is simply to be patient.
EURONEXT:MCLong
by SimeonNikolaev-invest
ICHR: Is the Pullback Over? Trendline BrokenStory: 📊 The Setup ICHR broke down hard from a $118 high into a multi-month downtrend, falling inside a clean descending trendline. Price is now testing the top of that structure right where the prior base (~$50-56) offered support before the original breakout. ⚡ The Signals Bullish divergence on the oscillator — a classic early-reversal tell. That divergence is now backed by price breaking above the descending trendline, on a volume spike. 🎯 Levels to Watch 🟢 Base support: $50 🔴 Immediate resistance: $59 - 62 — needs to be reclaimed to fill the gap 🔴 Resistance: $77 🔴 Resistance: $98 🧠 The Read: Divergence, trendline break, and volume together is a solid combination, but the trend isn't confirmed until $59-60 gets reclaimed and the gap fills. Until then, this is a pullback showing the first signs of stalling, not yet a confirmed reversal. Chart study, not financial advice.
NASDAQ:ICHRLong
by ibraheeemz
INTEGRA LIFESCIENCES HOLDINGS CORP (IART:US)INTEGRA LIFESCIENCES HOLDINGS CORP (IART:US) An entry point around $11.00 offers an excellent risk/reward ratio. However, for complete certainty, waiting for the next quarterly report to confirm that FCF is indeed reaching the expected $1.80+ remains the most prudent step. 💰 Accumulation Plan 🟡 $11.33 → 30% 🟠 $7.66→ 50% 🔴 $6.36 → 70% 🔴 $2.70 → 100% 🏦 Fundamentals → WHAT I want to own 📊 Technical Levels → WHERE I want to accumulate ⏳ Patience → WHEN I choose to act The market constantly creates imbalances. My job is simply to be patient.
NASDAQ:IARTLong
by SimeonNikolaev-invest
CRDO: Believe the Bottom Is In — Engulfing at EMA89Previoulsy shorted CRDO at 275 (See the attached post), now is the time to go long! Story: 📊 The Pattern Credo carved out a double bottom around $149 after a brutal drop of nearly 52% off its $308 top. This week printed a strong bullish engulfing candle — landing right on the rising weekly EMA89, which has acted as dynamic trend support through the entire 2023-2026 uptrend. ⚡ The Confirmation Volume came in at 48.4M on the reversal week, well above the recent average — real participation showing up exactly where structure (the double bottom) and trend (EMA89) converge, not just a quiet drift higher. 🎯 Levels to Watch 🟢 Structure support / double bottom: $149 🛑 Invalidation: a weekly close back below $148 breaks both the double bottom and the EMA89 confluence 🔴 Resistance 1: $199 🔴 Resistance 2: $245 🔴 Resistance 3: $275 🏔️ Stretch target: retest of the $308 top 🧠 The Read: A double bottom, a bullish engulfing reversal candle, and rising EMA89 support all lining up in the same zone, backed by a volume spike, is a fairly complete reversal signal set. The trend that carried this stock from single digits to $300+ still looks structurally intact above $149 — this reads more like a retest of trend support than a trend change. Chart study, not financial advice.
NASDAQ:CRDOLong
by ibraheeemz
POWL: Golden Pocket Bounce — Trendline HoldsStory: 📊 The Setup Powell Industries ran from ~$51 to an all-time high of $327, then corrected hard back into the 0.5-0.618 Fibonacci zone- the "golden pocket. This week's candle is a bullish engulfing bar printing right inside that pocket, closing at $183.96 after tagging a low of $167.31. 🧱 The Confluence Three independent things are lining up at the same spot: the rising trendline off the 2025 base, the horizontal support shelf at $167.76 and the fib golden pocket. A reversal candle printing at a triple-confluence zone like this carries more weight than one showing up in open air. 🎯 Levels to Watch 🟢 Structure support / trendline: $167 🛑 Deeper invalidation: I would place STOP below 165 on daily closing basis 🔴 Resistance 1 (first target): $219 🔴 Resistance 2: $261 🔴 Resistance 3: $298 🏔️ Stretch target: retest of the $327 all-time high 🧠 The Read: A pullback that respects trendline, horizontal support, and the golden pocket all at once, capped by a weekly engulfing candle, is one of the cleaner "buy the retracement" setups you'll see — the risk is well-defined (below the trendline/support) against a resumption of the prior uptrend.
NASDAQ:POWLLong
by ibraheeemz
BELLRING BRANDS INC (BRBR:US)BELLRING BRANDS INC (BRBR:US) BellRing Brands (BRBR) holds leading positions in the protein products market (Premier Protein & Dymatize)—a category benefiting from enduring global demographic trends favoring health and wellness. The stock currently trades at a highly attractive valuation (P/E ~7–8x), boasts an exceptionally high ROIC (>30%), and generates robust free cash flow used for share buybacks. While the company faces risks associated with its high debt load and a temporary slowdown in revenue growth, its fundamental value is significantly undervalued. 🏦 Fundamentals → WHAT I want to own 📊 Technical Levels → WHERE I want to accumulate ⏳ Patience → WHEN I choose to act The market constantly creates imbalances. My job is simply to be patient.
NYSE:BRBRLong
by SimeonNikolaev-invest
KRT |ML Pipeline Long Execution | Centroid 1 | XGB/GRU Review**Pipeline Output** Ticker: KRT Company: Karat Packaging Inc Date reviewed: 2026-06-11 Setup type: Long execution Centroid: 1 Centroid rank: 6 Sector: Industrials Close: 29.83 SMA9: 28.38 SMA50: 28.33 Volume: 97,832 **Why this is on my review list** KRT appeared in my pipeline as a current long execution. The setup triggered when the SMA9 crossed above the SMA50. This is not a manual chart pick. It is a review of what the pipeline produced. **Model Read** XGB p_up: 99.9999% GRU p_up: 99.9978% Both classification models were strongly aligned to the upside regime on this row. The regression side was more cautious, with both XGB and GRU showing slightly lower forward-price estimates. That makes this a regime-alignment setup where the classification read is stronger than the forward-price read. **Risk Reference** Close: 29.83 Initial stop/reference level: 27.31 The stop area gives a defined risk reference for reviewing how the setup behaves after the signal. **Follow-up Plan** I’ll review this setup in future updates as either an active open trade, a failed setup, or a completed trade outcome. **Source / Purpose** This chart is part of my daily machine-learning pipeline review. The ticker was selected from a model-generated scan using price, trend, trade-state, centroid grouping, and XGB/GRU probability outputs. The purpose is to document what the pipeline produced and then follow up on what happened afterward. This is a research journal and educational review, not financial advice or a recommendation to buy or sell.
NASDAQ:KRT
by Quant_Signal_Engine
2
CPRI | ML Pipeline Long Execution | Centroid 1 | XGB/GRU Review**Pipeline Output** Ticker: CPRI Company: Capri Holdings Ltd Date reviewed: 2026-06-11 Setup type: Long execution Centroid: 1 Centroid rank: 4 Sector: Consumer Discretionary Close: 20.85 SMA9: 19.16 SMA50: 19.07 Volume: 3,779,715 **Why this is on my review list** CPRI appeared in my pipeline as a current long execution. The setup triggered when the SMA9 crossed above the SMA50. This is not a manual chart pick. It is a review of what the pipeline produced. **Model Read** XGB p_up: 100.00% GRU p_up: 99.9965% Both classification models were strongly aligned to the upside regime on this row. The forward-price estimates were more restrained, with XGB nearly flat/slightly positive and GRU projecting a modest pullback. That makes this a useful example of strong regime agreement but less aggressive forward-price expectation. **Risk Reference** Close: 20.85 Initial stop/reference level: 18.18 The stop area gives a defined risk reference for reviewing how the setup behaves after the signal. **Follow-up Plan** I’ll review this setup in future updates as either an active open trade, a failed setup, or a completed trade outcome. **Source / Purpose** This chart is part of my daily machine-learning pipeline review. The ticker was selected from a model-generated scan using price, trend, trade-state, centroid grouping, and XGB/GRU probability outputs. The purpose is to document what the pipeline produced and then follow up on what happened afterward. This is a research journal and educational review, not financial advice or a recommendation to buy or sell.
NYSE:CPRILong
by Quant_Signal_Engine
SPIR: Buyers Came Early This timePrice has bounced from the lower boundary of its long-term rising channel, where buyers have consistently stepped in throughout the broader uptrend, just a bit sooner this time. 🟢 Bullish Engulfing Confirmation A bullish engulfing candle has formed directly off channel support, signaling renewed buying interest and increasing the probability of another advance. 📈 Ride the Channel As long as price continues to hold above the marked support and stop-loss zone, the path of least resistance remains higher. A move toward the 25%, 50%, and eventually the 75% channel levels becomes increasingly likely if momentum continues to build. 🎯 Trade Plan 🟢 Bias: Bullish while above support 🎯 Targets: 25% → 50% → 75% of the rising channel 🛡️ Invalidation: Weekly close below the highlighted support/SL 💡 Story in One Line A textbook rebound from long-term channel support, confirmed by a bullish engulfing candle, with room to ride the channel higher as long as support remains intact.
NYSE:SPIRLong
by ibraheeemz
HROW | Pipeline Long Execution | Centroid 1 | XGB/GRU Review **Pipeline Output** Ticker: HROW Company: HARROW INC Date reviewed: 2026-06-16 Setup type: Open trade follow-up Centroid: 2 Centroid rank: Sector: Health Care Close: 38.40 SMA9: SMA50: 36.41 Volume: 374,828 **Why this is on my review list** HROW appeared in my pipeline as a current long execution. The setup triggered when the EMA8 crossed above the SMA50. This is not a manual chart pick. It is a review of what the pipeline produced. **Model Read** XGB p_up: 79.16% GRU p_up: 73.23% Both classification models were moderately aligned to the upside regime on this row. **Risk Reference** Close: 38.40 Initial stop/reference level: 33.51 The stop area gives a defined risk reference for reviewing how the setup behaves after the signal. **Follow-up Plan** I’ll review this setup in future updates as either an active open trade, a failed setup, or a completed trade outcome. **Source / Purpose** This chart is part of my daily machine-learning pipeline review. The ticker was selected from a model-generated scan using price, trend, trade-state, centroid grouping, and XGB/GRU probability outputs. The purpose is to document what the pipeline produced and then follow up on what happened afterward. Quant Signal Engine This is a research journal and educational review, not financial advice or a recommendation to buy or sell.
NASDAQ:HROWLong
by Quant_Signal_Engine
MP: Channel Bounce Underway — Is $136 or $160 Next?As seen on the chart, there is a descending channel in play. Previously, price bounced right off the 76.61 level, roughly aligning with the 1.5 extension of the parallel channel. More recently, price rebounded off channel line 0 and rallied back up from 1.0 toward 0.5. If we get a solid bullish reaction from here, the 136 level could realistically be tested, a move further supported by prior earnings and fundamentals. Beyond that, even the 2.0 Fibonacci extension at 160 comes into play as a potential target. Right now, EVERYTHING hinges on how the price reacts at this level. ⭐️parallel channel 💸$136 💸 $$160 -icttrdr 🚀🚀
NYSE:MPLong
by icttrdr
MRNA | Pipeline Long Execution | Centroid 1 | XGB/GRU Review**Pipeline Output** Ticker: MRNA Company: MODERNA INC Date reviewed: 2026-06-16 Setup type: Open trade follow-up Centroid: 1 Centroid rank: Sector: Health Care Close: 55.40 SMA9: SMA50: 49.73 Volume: 13,014,863 **Why this is on my review list** MRNA appeared in my pipeline as a current long execution. The setup triggered when the EMA8 crossed above the SMA50. This is not a manual chart pick. It is a review of what the pipeline produced. **Model Read** XGB p_up: 90.99% GRU p_up: 82.08% Both classification models were strongly aligned to the upside regime on this row. **Risk Reference** Close: 55.40 Initial stop/reference level: 48.25 The stop area gives a defined risk reference for reviewing how the setup behaves after the signal. **Follow-up Plan** I’ll review this setup in future updates as either an active open trade, a failed setup, or a completed trade outcome. **Source / Purpose** This chart is part of my daily machine-learning pipeline review. The ticker was selected from a model-generated scan using price, trend, trade-state, centroid grouping, and XGB/GRU probability outputs. The purpose is to document what the pipeline produced and then follow up on what happened afterward. Quant Signal Engine This is a research journal and educational review, not financial advice or a recommendation to buy or sell.
NASDAQ:MRNALong
by Quant_Signal_Engine
Descending channel Breakout and Retest PACS broke out of a long-term descending channel, confirming a BOS and rallying to $43 — forming a double top / HH. Price has since pulled back to the breakout zone (~$35), where a confluence of support aligns: EMA 20, the former channel boundary, and the breakout gap. A reversal is now underway from what looks like the HL, with the EMA 20 already being reclaimed. Target: $43 retest, with extension toward $50- $55 on a clean breakout.
NYSE:PACSLong
by ibraheeemz